EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 41 / No 3 (September 2009) J Extra Corpor Technol, 41 3 (2009) 149-156 References
Free Access
Issue
J Extra Corpor Technol
Volume 41, Number 3, September 2009
Page(s) 149 - 156
DOI https://doi.org/10.1051/ject/200941149
Published online 15 September 2009
  1. Asimakopoulos G, Gourlay T. A review of anti-inflammatory strategies in cardiac surgery. Perfusion. 2003;18(Suppl 1):7–12. [CrossRef] [PubMed] [Google Scholar]
  2. De Somer F. Optimization of the perfusion circuit and its possible impact on the inflammatory response. J Extra Corpor Technol. 2007;39:285–8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Rimpilainen R, Biancari F, Wistbacka J, et al. Outcome after coronary artery bypass surgery with miniaturized versus conventional cardio-pulmonary bypass. Perfusion. 2008;23:361–7. [CrossRef] [PubMed] [Google Scholar]
  4. Gunaydin S, McCusker K, Vijay V. Strategic leukofiltration in cardiac surgery. Curr Med Chem Cardiovasc Hematol Agents. 2005;3:323–31. [CrossRef] [PubMed] [Google Scholar]
  5. Matheis G, Scholz M, Simon A, Henrich D, Wimmer-Greinecker G, Moritz A. Timing of leukocyte filtration during cardiopulmonary bypass. Perfusion. 2001;16(Suppl):31–7. [CrossRef] [PubMed] [Google Scholar]
  6. Asimakopoulos G. The inflammatory response to CPB: The role of leukocyte filtration. Perfusion. 2002;17(Suppl):7–10. [CrossRef] [PubMed] [Google Scholar]
  7. Modine T, Azzaoui R, Ouk T, et al. Changes in cerebral vascular reactivity occur early during cardiopulmonary bypass in the rat. Ann Thorac Surg. 2006;82:672–8. [CrossRef] [Google Scholar]
  8. Gunaydin S, McCusker K, Vijay V, et al. Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts. Perfusion. 2006;21:329–42. [CrossRef] [PubMed] [Google Scholar]
  9. Gunaydin S, Sari T, McCusker K, et al. Clinical evaluation of strategic leukofiltration with surface modification: Enhanced preservation or fantasy. Filtration. 2005;1:47–58. [Google Scholar]
  10. Gunaydin S, McCusker K, Vijay V, et al. Clinical significance of strategic leukocyte filtration in different risk cohorts undergoing cardiac surgery. Filtration. 2005;1:95–106. [Google Scholar]
  11. Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg. 2005;3:129–40. [CrossRef] [Google Scholar]
  12. Gourlay T, Fleming J, Taylor KM. Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter. Perfusion. 1992;7:131–40. [CrossRef] [PubMed] [Google Scholar]
  13. Fontes ML, Mathew JP, Rinder HM, Zelterman D, Smith BR, Rinder CS; Multicenter Study of Perioperative Ischemia. (McSPI) Research Group Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg. 2005;101:17–23. [CrossRef] [PubMed] [Google Scholar]
  14. Gunaydin S, Ayrancioglu K, Dikmen E, et al. Clinical effects of leukofiltration and surface modification on post-cardiopulmonary bypass atrial fibrillation in different risk cohorts. Perfusion. 2007;22:279–88. [CrossRef] [PubMed] [Google Scholar]
  15. Ogiwara M, Kyo S, Ohuchi H, et al. High pressure occlusion of leukocyte depletion arterial line filter in patients with cardio-pulmonary bypass surgery. Kyobu Geka. 2001;54:759–63. [PubMed] [Google Scholar]
  16. Noh H, Fogler EA. Volumetric interpretation of protein adsorption: Competition from mixtures and the Vroman effect. Biomaterials. 2007;28:405–22. [CrossRef] [PubMed] [Google Scholar]
  17. Patel AN, Sutton SW, Livingston S, et al. Clinical benefits of leukocyte filtration during valve surgery. Am J Surg. 2003;186:636–9, discussion 639-40. [CrossRef] [Google Scholar]
  18. Whitaker DC, Stygall JA, Newman SP, Harrison MJ. The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: A systematic review of clinical studies. Perfusion. 2001;16:433–46. [CrossRef] [PubMed] [Google Scholar]
  19. Leal-Noval SR, Amaya R, Herruzo A, et al. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: A controlled randomized trial. Ann Thorac Surg. 2005;80:1394–400. [CrossRef] [Google Scholar]
  20. Scholz M, Simon A, Matheis G, et al. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res. 2002;51:363–8. [CrossRef] [PubMed] [Google Scholar]
  21. Sahlman A, Ahonen J, Salo JA, Rämö OJ. No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anaesthesiol Scand. 2001;45:558–63. [CrossRef] [Google Scholar]
  22. Royston D, Kovesi T, Marczin N. The unwanted response to cardiac surgery: Time for a reappraisal? J Thorac Cardiovasc Surg. 2003;125:32–5. [CrossRef] [Google Scholar]
  23. Landis RC, Arrowsmith JE, Baker RA, et al. Consensus statement: Defining minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum. 2008;11:E316–22. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.